Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In the peptide therapy context, AbbVie's Lupron (leuprolide) franchise treating prostate cancer, endometriosis, uterine fibroids, and precocious puberty via GnRH agonism remains a stable legacy contributor, while Botox Therapeutic ($748 million in Q1 2024 alone) constitutes a significant peptide-adjacent revenue stream
The compound elevates GH and IGF-1 within physiological ranges when administered at 2mg daily
Retatrutides 24.2% at 12 mg over 48 weeks represents approximately 60% greater efficacy in a shorter timeframe
Yet the WHO noted that prices remain a major barrier
Jul 2013;7(14):188-98
In some cases, a healthcare provider may recommend a combination of HRT and GLP-1s as part of your treatment plan
